PTJ
FCSC

Paul Tudor Jones’s Fibrocell Science Inc. FCSC Stock Holding History

Paul Tudor Jones’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,667
Closed -$438K – 1399
2013
Q3 		$438K Buy
+6,667
New +$539K 0.02% 412

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's FCSC Position: Q4 2013 in Review

Paul Tudor Jones sold out of Fibrocell Science Inc. (FCSC) in Q4 2013, closing a stake of 6,667 shares — an estimated $438K sold.

Paul Tudor Jones first reported a position in FCSC in Q3 2013 and held it in 1 quarter. The position peaked at $438K in Q3 2013. 43 funds tracked by Wall St. Rank hold FCSC as of Q4 2013.

  • Paul Tudor Jones reported no remaining Fibrocell Science Inc. position as of Q4 2013 after selling out during the quarter.
  • Paul Tudor Jones sold 6,667 Fibrocell Science Inc. shares in Q4 2013, an estimated $438K.
  • Paul Tudor Jones first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 1 quarter.
  • Paul Tudor Jones's Fibrocell Science Inc. position peaked at $438K in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2013.

Based on Tudor Investment Corp's 13F filing for Q4 2013, filed 14 Feb 2014.